I am a
Home I AM A Search Login

Papers of the Week


2022 Nov


Pain Physician


25


8

Immunosuppressive Effect of Intrathecal Morphine, Dexmedetomidine, or Both in Combination with Bupivacaine on Patients Undergoing Major Abdominal Cancer Surgery.

Authors

Kamal S M, Mohamed S A-B, Fares K M, Abdelemam R M, Elmasry H M, Mansour S
Pain Physician. 2022 Nov; 25(8):555-567.
PMID: 36375185.

Abstract

An impaired immune system in the perioperative period has important clinical implications in patients with cancer. Despite the immunosuppressive properties of opioid therapy, it is still commonly utilized in the intrathecal or epidural space for the treatment of postoperative pain. Also, intrathecal dexmedetomidine has extended analgesic efficacy in postoperative pain; it can significantly affect immune function in perioperative patients.